Vimarsana
Biggest News Aggregation in the World

Page 35 - Mortality Weekly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mortality Weekly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mortality Weekly Today - Breaking & Trending Today

COPD Prevalence Did Not Significantly Change Overall From 2011 to 2021, Study Says - Vimarsana News

COPD Prevalence Did Not Significantly Change Overall From 2011 to 2021, Study Says

Based on Behavioral Risk Factor Surveillance System data, about 6.4% of US adults in 2011 (14.3 million people) and about 6.5% (14.2 million) had COPD in 2021, showing that COPD prevalence did not significantly change throughout the decade.

Source: ajmc.com
Health Care Personnel Influenza Vaccination Coverage Declined After COVID-19 Pandemic, Study Says - Vimarsana News

Health Care Personnel Influenza Vaccination Coverage Declined After COVID-19 Pandemic, Study Says

Researchers hypothesized that health care personnel (HCP) influenza vaccination coverage decreased during the pandemic because individuals may have believed that it was less important than in previous years.

Source: ajmc.com
FDA clears first at-home collection test for chlamydia, gonorrhea - Vimarsana News

FDA clears first at-home collection test for chlamydia, gonorrhea

The FDA said the test offers a private and quick testing option, along with streamlined treatment, if needed.

Source: umn.edu
WHO and CDC warn of rising measles cases and deaths - Vimarsana News

WHO and CDC warn of rising measles cases and deaths

Low-income countries were hit hardest by coverage gaps and deaths from the virus.  

Source: umn.edu
Quick takes: More Beyfortus doses for RSV, avian flu on Iowa farm, gain-of-function in hot seat - Vimarsana News

Quick takes: More Beyfortus doses for RSV, avian flu on Iowa farm, gain-of-function in hot seat

Health officials are releasing 77,000 more doses, with supply stretched by higher-than-expected demand for the new tool for protecting newborns.

Source: umn.edu